Therapeutic targeting of the complement system: from rare diseases to pandemics

P Garred, AJ Tenner, TE Mollnes - Pharmacological reviews, 2021 - ASPET
The complement system was discovered at the end of the 19th century as a heat-labile
plasma component that “complemented” the antibodies in killing microbes, hence the name …

The pathogenesis of end-stage renal disease from the standpoint of the theory of general pathological processes of inflammation

E Gusev, L Solomatina, Y Zhuravleva… - International journal of …, 2021 - mdpi.com
Chronic kidney disease can progress to end-stage chronic renal disease (ESRD), which
requires the use of replacement therapy (dialysis or kidney transplant) in life-threatening …

Complementopathies and precision medicine

E Gavriilaki, RA Brodsky - The Journal of clinical …, 2020 - Am Soc Clin Investig
The renaissance of complement diagnostics and therapeutics has introduced precision
medicine into a widened field of complement-mediated diseases. In particular, complement …

Deposition of the membrane attack complex in healthy and diseased human kidneys

JJE Koopman, MF Van Essen, HG Rennke… - Frontiers in …, 2021 - frontiersin.org
The membrane attack complex—also known as C5b-9—is the end-product of the classical,
lectin, and alternative complement pathways. It is thought to play an important role in the …

The role of immune modulation in pathogenesis of IgA nephropathy

S Chang, XK Li - Frontiers in Medicine, 2020 - frontiersin.org
IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis worldwide, with
diverse clinical manifestations characterized by recurrent gross hematuria or microscopic …

An update on targeted treatment of IgA nephropathy: an autoimmune perspective

X Huang, G Xu - Frontiers in pharmacology, 2021 - frontiersin.org
Immunoglobulin (Ig) A nephropathy (IgAN) is the commonest form of primary
glomerulonephritis worldwide and is, considered a significant cause of end-stage renal …

Aberrantly glycosylated IgA1 in IgA nephropathy: What we know and what we don't know

Y Ohyama, MB Renfrow, J Novak… - Journal of Clinical …, 2021 - mdpi.com
IgA nephropathy (IgAN), the most common primary glomerular disease worldwide, is
characterized by glomerular deposition of IgA1-containing immune complexes. The IgA1 …

Immunological drivers of IgA nephropathy: Exploring the mucosa–kidney link

H Selvaskandan, J Barratt… - International Journal of …, 2022 - Wiley Online Library
IgA nephropathy (IgAN) is the most common pattern of primary glomerular disease reported
worldwide. Up to 40% of those with IgAN progress to end‐stage kidney disease within 20 …

A personalized update on IgA nephropathy: a new vision and new future challenges

E Gutiérrez, F Carvaca-Fontán, L Luzardo, E Morales… - Nephron, 2020 - karger.com
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …

Targeting complement in IgA nephropathy

F Caravaca-Fontán, E Gutiérrez… - Clinical Kidney …, 2023 - academic.oup.com
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide. Recent years have witnessed significant improvements in the understanding of …